129S2/SvPas-Ins2tm1Jja/Orl

Status

Available to order

EMMA IDEM:01218
International strain name129S2/SvPas-Ins2tm1Jja/Orl
Alternative nameIns/2_LacZ_129
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolIns2tm1Jja
Gene/Transgene symbolIns2

Information from provider

ProviderJacques Jami
Provider affiliationEndocrinologie pédiatrique, INSERM U561, Groupe Hospitalier Cochin - Saint Vincent de Paul, Institut Cochin
Genetic informationThese mice carry a knock-out mutation of the gene coding for mouse proinsulin-2 (Ins2, or insulin II) and express LacZ in their islets. This property can be used for tracking proinsulin-2 expressing cells in the islets or thymus (see Chentoufi et al Diabetes 2004).
Phenotypic informationDeficiency of proinsulin expression by thymic epithelial cells
References
  • Phenotypic alterations in insulin-deficient mutant mice.;Duvillié B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier J M, Monthioux E, Jami J, Joshi R L, Bucchini D, ;1997;Proceedings of the National Academy of Sciences of the United States of America;94;5137-40; 9144203

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

MGI allele-associated human disease models

MGI phenotypes (allele matching)
  • decreased pancreatic beta cell number / MGI
  • abnormal glucose homeostasis / MGI
  • increased anti-insulin autoantibody level / MGI
  • insulitis / MGI
  • increased insulin secretion / MGI
  • increased pancreatic beta cell number / MGI
  • increased pancreatic beta cell mass / MGI
MGI phenotypes (gene matching)
  • decreased bone mineral density / MGI
  • abnormal microglial cell morphology / MGI
  • kyphosis / MGI
  • increased leukocyte cell number / MGI
  • hydronephrosis / MGI
  • decreased body weight / MGI
  • increased anxiety-related response / MGI
  • hypoactivity / MGI
  • polydipsia / MGI
  • dehydration / MGI
  • polyphagia / MGI
  • hyperglycemia / MGI
  • postnatal growth retardation / MGI
  • increased urine glucose level / MGI
  • polyuria / MGI
  • abnormal glucose homeostasis / MGI
  • postnatal lethality / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • abnormal astrocyte morphology / MGI
  • increased circulating ketone body level / MGI
  • hepatic steatosis / MGI
  • akinesia / MGI
  • abnormal pancreas physiology / MGI
  • decreased circulating insulin level / MGI
  • abnormal Leydig cell morphology / MGI
  • abnormal retinal vasculature morphology / MGI
  • increased anti-insulin autoantibody level / MGI
  • albuminuria / MGI
  • increased insulin sensitivity / MGI
  • no phenotypic analysis / MGI
  • increased insulin secretion / MGI
  • decreased insulin secretion / MGI
  • increased vascular permeability / MGI
  • decreased pancreatic beta cell number / MGI
  • abnormal pancreatic beta cell physiology / MGI
  • increased pancreatic beta cell number / MGI
  • insulitis / MGI
  • increased susceptibility to autoimmune diabetes / MGI
  • abnormal pancreatic islet morphology / MGI
  • abnormal pancreatic alpha cell morphology / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • abnormal retinal ganglion layer morphology / MGI
  • glomerulosclerosis / MGI
  • impaired glucose tolerance / MGI
  • insulin resistance / MGI
  • homeostasis/metabolism phenotype / MGI
  • increased renal glomerular filtration rate / MGI
  • increased circulating glucose level / MGI
  • decreased circulating leptin level / MGI
  • abnormal response to transplant / MGI
  • abnormal mitochondrion morphology / MGI
  • abnormal retinal neuronal layer morphology / MGI
  • hematoma / MGI
  • decreased subcutaneous adipose tissue amount / MGI
  • increased pancreatic beta cell mass / MGI
  • decreased pancreatic beta cell mass / MGI
  • small pancreatic islets / MGI
  • absent pancreatic beta cells / MGI
  • increased pancreatic alpha cell number / MGI
  • decreased pancreatic alpha cell number / MGI
  • disorganized pancreatic islets / MGI
  • degranulated pancreatic beta cells / MGI
  • postnatal lethality, complete penetrance / MGI
  • abnormal glomerular capillary morphology / MGI
  • expanded mesangial matrix / MGI
  • increased renal glomerulus basement membrane thickness / MGI
  • abnormal kidney interstitium morphology / MGI
  • increased food intake / MGI
  • increased fluid intake / MGI
  • increased pancreatic islet cell apoptosis / MGI
  • renal glomerular protein deposits / MGI
  • increased retinal apoptosis / MGI

Literature references

  • Phenotypic alterations in insulin-deficient mutant mice.;Duvillié B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier J M, Monthioux E, Jami J, Joshi R L, Bucchini D, ;1997;Proceedings of the National Academy of Sciences of the United States of America;94;5137-40; 9144203

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).